Single User License
INR 170050
Site License
INR 340100
Corporate User License
INR 510150

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Nasal Polyposis Global Clinical Trials Review, H2

Nasal Polyposis Global Clinical Trials Review, H2


  Request for Sample Report

Executive Summary

Nasal Polyposis Global Clinical Trials Review, H2, 2015

GlobalData's clinical trial report, "Nasal Polyposis Global Clinical Trials Review, H2, 2015" provides an overview of Nasal Polyposis clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Polyposis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Nasal Polyposis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Nasal Polyposis to Ear Nose Throat Disorders Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by Phase 17

In Progress Trials by Phase 18

Clinical Trials by Trial Status 19

Clinical Trials by End Point Status 20

Unaccomplished Trials of Nasal Polyposis 21

Subjects Recruited Over a Period of Time 22

Clinical Trials by Sponsor Type 23

Prominent Sponsors 24

Top Companies Participating in Nasal Polyposis Therapeutics Clinical Trials 25

Prominent Drugs 26

Clinical Trial Profiles 27

Clinical Trial Overview of Top Companies 27

Sanofi 27

Clinical Trial Overview of Sanofi 27

Regeneron Pharmaceuticals, Inc. 28

Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 28

Optinose US Inc. 29

Clinical Trial Overview of Optinose US Inc. 29

SC Clinical Research, Inc 30

Clinical Trial Overview of SC Clinical Research, Inc 30

PARI Medical Holding GmbH 31

Clinical Trial Overview of PARI Medical Holding GmbH 31

Optimed Research, LTD. 32

Clinical Trial Overview of Optimed Research, LTD. 32

Merck & Co., Inc. 33

Clinical Trial Overview of Merck & Co., Inc. 33

Intersect ENT Inc. 34

Clinical Trial Overview of Intersect ENT Inc. 34

GlaxoSmithKline Plc 35

Clinical Trial Overview of GlaxoSmithKline Plc 35

F. Hoffmann-La Roche Ltd. 36

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36

Clinical Trial Overview of Top Institutes / Government 37

Hamedan University of Medical Sciences 37

Clinical Trial Overview of Hamedan University of Medical Sciences 37

Massachusetts General Hospital 38

Clinical Trial Overview of Massachusetts General Hospital 38

Ghent University Hospital 39

Clinical Trial Overview of Ghent University Hospital 39

Isfahan University of Medical Sciences 40

Clinical Trial Overview of Isfahan University of Medical Sciences 40

Johannes Gutenberg University Mainz 41

Clinical Trial Overview of Johannes Gutenberg University Mainz 41

St. Elizabeth's Medical Center 42

Clinical Trial Overview of St. Elizabeth's Medical Center 42

University of Alberta 43

Clinical Trial Overview of University of Alberta 43

Five Key Clinical Profiles 44

Appendix 67

Abbreviations 67

Definitions 67

Research Methodology 68

Secondary Research 68

About GlobalData 69

Contact Us 69

Disclaimer 69

Source 70

List of Figures

Nasal Polyposis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Nasal Polyposis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Nasal Polyposis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Nasal Polyposis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Nasal Polyposis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Nasal Polyposis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Nasal Polyposis to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 14

Nasal Polyposis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Nasal Polyposis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Nasal Polyposis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17

Nasal Polyposis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18

Nasal Polyposis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19

Nasal Polyposis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20

Nasal Polyposis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22

Nasal Polyposis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23

Nasal Polyposis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24

Nasal Polyposis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25

Nasal Polyposis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26

GlobalData Methodology 68

List of Tables

Nasal Polyposis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Nasal Polyposis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Nasal Polyposis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Nasal Polyposis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Nasal Polyposis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Nasal Polyposis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Nasal Polyposis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Proportion of Nasal Polyposis to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 14

Nasal Polyposis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Nasal Polyposis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Nasal Polyposis Therapeutics, Global, Clinical Trials by Phase, 2015* 17

Nasal Polyposis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18

Nasal Polyposis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19

Nasal Polyposis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20

Nasal Polyposis Therapeutics, Global, Terminated Clinical Trials, 2015* 21

Nasal Polyposis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22

Nasal Polyposis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23

Nasal Polyposis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24

Nasal Polyposis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25

Nasal Polyposis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 27

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015* 28

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Optinose US Inc., 2015* 29

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by SC Clinical Research, Inc, 2015* 30

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by PARI Medical Holding GmbH, 2015* 31

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Optimed Research, LTD., 2015* 32

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 33

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Intersect ENT Inc., 2015* 34

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 35

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 36

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamedan University of Medical Sciences, 2015* 37

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 38

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2015* 39

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 40

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johannes Gutenberg University Mainz, 2015* 41

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Elizabeth's Medical Center, 2015* 42

Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2015* 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sanofi

Regeneron Pharmaceuticals, Inc.

Optinose US Inc.

SC Clinical Research, Inc

PARI Medical Holding GmbH

Optimed Research, LTD.

Merck & Co., Inc.

Intersect ENT Inc.

GlaxoSmithKline Plc

F. Hoffmann-La Roche Ltd.

Nasal Polyposis Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Nasal Polyposis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com